Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus bupropion versus placebo for painful diabetic neuropathy
IRCT20260105068551N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in diabetic polyneuropathy (DPN) comparing Bupropion, Duloxetine and Placebo control (3 arms). Primary endpoint: Neuropathic pain intensity. Started Jan 2026; status: completed.
02
Drugs
bupropionduloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20260105068551N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260105068551N1.